Contact
Contact Investor portal

About us

Strategies

Portfolio

Team

Sustainability

News & Insights

/

Strategies

At Forbion, we invest in life sciences innovations that improve both human and planetary health. Our Human Health strategy focuses on advancing therapies that address unmet medical needs, while our Planetary Health strategy supports biotech-enabled solutions for sustainable food, agriculture, and environmental practices.

MAn in glasses with computer code reflecting off of them
Woman in safety goggles

Impacting the future

About

Forbion’s Human Health investment strategy supports innovative biopharmaceutical companies tackling significant unmet medical needs through a comprehensive, long-term approach. We invest across three key stages: seed funding via our joint venture with BGV, company building through our Ventures strategy, and company expansion with our Growth strategy. By combining stage-specific capital with deep sector expertise and hands-on support, we help ambitious teams develop transformative therapies and build enduring companies that advance human health globally.

Areas of interest

Strategies

Supporting human health biotech companies throughout all stages of development.

Close up of some cells

Immunology & Inflammation

Innovative treatments focus on balancing immune responses and reducing inflammation to improve quality of life.

Portfolio businesses
Heart monitor machine

Cardiovascular / Metabolic

Developing therapies for cardiovascular and metabolic diseases, like diabetes, obesity, and dyslipidemia, targeting prevention, management, and treatment.

Portfolio businesses
Image of Central Nervous System

Central Nervous System

Developing and delivering treatments for central nervous system disorders, including diseases affecting the brain and spinal cord.

Portfolio businesses
Little girl looking up at mother

Oncology

Researching, developing, and commercializing cancer treatments, encompassing discovery and clinical trials of innovative cancer therapies.

Portfolio businesses
MAn looking through medical machineary

Ophthalmology

Develops therapies for eye diseases such as macular degeneration, diabetic retinopathy, and inherited retinal disorders, improving vision and patient outcomes.

Portfolio businesses
Close up of digitally created dna image

Rare & Genetic Disorders

Develops therapies for conditions like cystic fibrosis, Duchenne muscular dystrophy, and lysosomal storage disorders, addressing high unmet medical needs.

Portfolio businesses
Xray of lungs

Respiratory

Developing treatments for diseases such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis, aiming to improve lung function and patient quality of life.

Portfolio businesses
Pink abstract graphic

Nephrology

Developing treatments for diseases affecting the kidneys. It includes conditions such as chronic kidney disease, acute kidney injury, IgA nephropathy, glomerulonephritis and hypertension-related kidney damage.

Portfolio businesses
Person pipetting pink droplets into dish

Infectious diseases

Developing treatments for diseases caused by pathogenic microorganisms such as bacteria, viruses, and fungi. It includes the development of therapeutics and preventive approaches, such as vaccines.

Portfolio businesses
First and BGV logos
Formation
Forbion Ventures logo
Ventures
Forbion Growth logo
Growth
Coral image with bright colours

Impacting the future of the planet

About

The Forbion BioEconomy Fund focuses on innovative companies that leverage biotechnology to clean and feed the planet across four sectors: Food, Agriculture, Materials and Environmental Technologies.

BioEconomy

Areas of interest

Strategies

Supporting innovative companies that leverage biotechnology to clean and feed the planet.

Gloved hands handling a pipette and food in dishes

Food

Food: Companies that establish new production processes for novel foods and food ingredients that leverage biotechnology to improve efficiencies and create more sustainable and more supply chain-resilient solutions compared to incumbent solutions.

Portfolio businesses
Image of plants growing within a plastic tube

Agriculture

Agriculture: Advancing sustainable practices in agriculture to grow food products more sustainably, with less reliance on petrochemical inputs and leveraging biotechnology to become more resilient to climate-related challenges in agriculture.

Portfolio businesses
Hand with lots of blue and white plastic pills piled up

Materials

Materials: Companies that leverage biomanufacturing and biological inputs to replace fossil-fuel based products with more sustainable solutions, without compromising on performance or price.

Portfolio businesses
Image of sky within a circle of trees

Environmental Technologies

Using biotechnology and green chemistry to clean the atmosphere, turn waste water into valuable resouces and transform industries to become more sustainable and circular.

Portfolio businesses
Forbion Bioeconomy logo

Forbion BioEconomy

Forbion BioEconomy invests in biotech innovation to transform critical industries impacting the future of our planet. 

View BioEconomy

Subscribe